A?dry-powder inhaler?(DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat?respiratory diseases?such as?asthma,?bronchitis,?emphysema?and?COPD?although DPIs (such as?Inhalable insulin) have also been used in the treatment of?diabetes mellitus.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Dry Powder Inhaler industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Single Dose
Multi-dose
Market Segment by Product Application
Asthma
COPD
Other
Finally, the report provides detailed profile and data information analysis of leading company.
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
3M
Hovione
Mannkind
Mylan
Novartis
Schering/Merck
Teva
Vectura
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Dry Powder Inhaler consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Dry Powder Inhaler market by identifying its various subsegments.
3.Focuses on the key global Dry Powder Inhaler manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Dry Powder Inhaler with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Dry Powder Inhaler submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Dry Powder Inhaler Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Dry Powder Inhaler Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Dry Powder Inhaler Segment by Type
2.1.1 Single Dose
2.1.2 Multi-dose
2.2 Market Analysis by Application
2.2.1 Asthma
2.2.2 COPD
2.2.3 Other
2.3 Global Dry Powder Inhaler Market Comparison by Regions (2017-2027)
2.3.1 Global Dry Powder Inhaler Market Size (2017-2027)
2.3.2 North America Dry Powder Inhaler Status and Prospect (2017-2027)
2.3.3 Europe Dry Powder Inhaler Status and Prospect (2017-2027)
2.3.4 China Dry Powder Inhaler Status and Prospect (2017-2027)
2.3.5 Japan Dry Powder Inhaler Status and Prospect (2017-2027)
2.3.6 Southeast Asia Dry Powder Inhaler Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Dry Powder Inhaler Industry Impact
2.5.1 Dry Powder Inhaler Business Impact Assessment - Covid-19
2.5.2 Market Trends and Dry Powder Inhaler Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Dry Powder Inhaler Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Dry Powder Inhaler Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Dry Powder Inhaler Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Dry Powder Inhaler Manufacturer Market Share
3.5 Top 10 Dry Powder Inhaler Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Dry Powder Inhaler Market
3.7 Key Manufacturers Dry Powder Inhaler Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Dry Powder Inhaler Industry Key Manufacturers
4.1 GlaxoSmithKline
4.1.1 Compan Detail
4.1.2 GlaxoSmithKline Dry Powder Inhaler Product Introduction, Application and Specification
4.1.3 GlaxoSmithKline 160 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 GlaxoSmithKline News
4.2 AstraZeneca
4.2.1 Compan Detail
4.2.2 AstraZeneca Dry Powder Inhaler Product Introduction, Application and Specification
4.2.3 AstraZeneca Dry Powder Inhaler Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 GlaxoSmithKline News
4.3 Boehringer Ingelheim
4.3.1 Compan Detail
4.3.2 Boehringer Ingelheim Dry Powder Inhaler Product Introduction, Application and Specification
4.3.3 Boehringer Ingelheim Dry Powder Inhaler Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Boehringer Ingelheim News
4.4 Chiesi
4.4.1 Compan Detail
4.4.2 Chiesi Dry Powder Inhaler Product Introduction, Application and Specification
4.4.3 Chiesi Dry Powder Inhaler Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Chiesi News
4.5 Cipla
4.5.1 Compan Detail
4.5.2 Chiesi Dry Powder Inhaler Product Introduction, Application and Specification
4.5.3 Cipla Dry Powder Inhaler Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Cipla News
4.6 3M
4.6.1 Compan Detail
4.6.2 3M Dry Powder Inhaler Product Introduction, Application and Specification
4.6.3 3M Dry Powder Inhaler Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 3M News
4.7 Hovione
4.7.1 Compan Detail
4.7.2 Hovione Dry Powder Inhaler Product Introduction, Application and Specification
4.7.3 Hovione Dry Powder Inhaler Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Mannkind
4.8.1 Compan Detail
4.8.2 Mannkind Dry Powder Inhaler Product Introduction, Application and Specification
4.8.3 Mannkind Dry Powder Inhaler Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Mannkind News
4.9 Mylan
4.9.1 Compan Detail
4.9.2 Mylan Dry Powder Inhaler Product Introduction, Application and Specification
4.9.3 Mylan Dry Powder Inhaler Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Mylan News
4.10 Novartis
4.10.1 Compan Detail
4.10.2 Novartis Dry Powder Inhaler Product Introduction, Application and Specification
4.10.3 Novartis Dry Powder Inhaler Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Novartis News
4.11 Schering/Merck
4.11.1 Compan Detail
4.11.2 Schering/Merck Dry Powder Inhaler Product Introduction, Application and Specification
4.11.3 Schering/Merck Dry Powder Inhaler Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Schering/Merck News
4.12 Teva
4.12.1 Compan Detail
4.12.2 Teva Dry Powder Inhaler Product Introduction, Application and Specification
4.12.3 Teva Dry Powder Inhaler Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Teva News
4.13 Vectura
4.13.1 Company Details
4.13.2 Vectura Dry Powder Inhaler Product Introduction, Application and Specification
4.13.3 Vectura Dry Powder Inhaler Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.13.4 Main Business Overview
4.13.5 Vectura News
5 Global Dry Powder Inhaler Market Segment by Big Type
5.1 Global Dry Powder Inhaler Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Dry Powder Inhaler Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Dry Powder Inhaler Revenue and Market Share by Big Type (2017-2022)
5.2 Single Dose Sales Growth Rate and Price
5.2.1 Global Single Dose Sales Growth Rate (2017-2022)
5.2.2 Global Single Dose Price (2017-2022)
5.3 Multi-dose Sales Growth Rate and Price
5.3.1 Global Multi-dose Sales Growth Rate (2017-2022)
5.3.2 Global Multi-dose Price (2017-2022)
6 Global Dry Powder Inhaler Market Segment by Big Application
6.1 Global Dry Powder Inhaler Sales Market Share by Big Application (2017-2022)
6.2 Asthma Sales Growth Rate (2017-2022)
6.3 COPD Sales Growth Rate (2017-2022)
6.4 Other Sales Growth Rate (2017-2022)
7 Global Dry Powder Inhaler Forecast
7.1 Global Dry Powder Inhaler Revenue, Sales and Growth Rate (2022-2027)
7.2 Dry Powder Inhaler Market Forecast by Regions (2022-2027)
7.2.1 North America Dry Powder Inhaler Market Forecast (2022-2027)
7.2.2 Europe Dry Powder Inhaler Market Forecast (2022-2027)
7.2.3 China Dry Powder Inhaler Market Forecast (2022-2027)
7.2.4 Japan Dry Powder Inhaler Market Forecast (2022-2027)
7.2.5 Southeast Asia Dry Powder Inhaler Market Forecast (2022-2027)
7.2.6 Other Regions Dry Powder Inhaler Market Forecast (2022-2027)
7.3 Dry Powder Inhaler Market Forecast by Type (2022-2027)
7.3.1 Global Dry Powder Inhaler Sales Forecast by Type (2022-2027)
7.3.2 Global Dry Powder Inhaler Market Share Forecast by Type (2022-2027)
7.4 Dry Powder Inhaler Market Forecast by Application (2022-2027)
7.4.1 Global Dry Powder Inhaler Sales Forecast by Application (2022-2027)
7.4.2 Global Dry Powder Inhaler Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Dry Powder Inhaler Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Dry Powder Inhaler Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Dry Powder Inhaler
Figure Market Concentration Ratio and Market Maturity Analysis of Dry Powder Inhaler
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Dry Powder Inhaler Market Size by Big Type
Figure Global Market Share of Dry Powder Inhaler by Big Type in 2021
Figure Single Dose Picture (2017-2022)
Global Dry Powder Inhaler Market Size by Big Application
Table Global Dry Powder Inhaler Market Size by Application
Figure Global Dry Powder Inhaler Market Share by Big Application in 2021
Figure Asthma Picture
Figure COPD Picture
Figure Other Picture
Table Global Dry Powder Inhaler Comparison by Regions (M USD) ?2017-2027?
Figure Global Dry Powder Inhaler Market Size (Million US$) (2017-2027)
Figure North America Dry Powder Inhaler Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Dry Powder Inhaler Revenue (Million US$) Growth Rate (2017-2027)
Figure China Dry Powder Inhaler Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Dry Powder Inhaler Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Dry Powder Inhaler Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Dry Powder Inhaler Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Dry Powder Inhaler Sales by Manufacturer (2017-2022)
Figure Global Dry Powder Inhaler Sales Market Share by Manufacturer in 2021
Table Global Dry Powder Inhaler Revenue by Manufacturer (2017-2022)
Figure Global Dry Powder Inhaler Revenue Market Share by Manufacturer in 2021
Table Global Dry Powder Inhaler Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Dry Powder Inhaler Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Dry Powder Inhaler Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Dry Powder Inhaler Market
Table Key Manufacturers Dry Powder Inhaler Product Type
Table Mergers & Acquisitions Planning
Table GlaxoSmithKline Company Profile
Table Dry Powder Inhaler Product Introduction, Application and Specification of GlaxoSmithKline
Table Dry Powder Inhaler Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table AstraZeneca Company Profile
Table Dry Powder Inhaler Product Introduction, Application and Specification of AstraZeneca
Table Dry Powder Inhaler Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table AstraZeneca Recent Development
Table Boehringer Ingelheim Company Profile
Table Dry Powder Inhaler Product Introduction, Application and Specification of Boehringer Ingelheim
Table Dry Powder Inhaler Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Boehringer Ingelheim Main Business
Table Boehringer Ingelheim Recent Development
Table Chiesi Company Profile
Table Dry Powder Inhaler Product Introduction, Application and Specification of Chiesi
Table Dry Powder Inhaler Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Chiesi Main Business
Table Chiesi Recent Development
Table Chiesi Main Business
Table Chiesi Recent Development
Table Cipla Company Profile
Table Dry Powder Inhaler Product Introduction, Application and Specification of Cipla
Table Dry Powder Inhaler Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Cipla Main Business
Table Cipla Recent Development
Table 3M Company Profile
Table Dry Powder Inhaler Product Introduction, Application and Specification of 3M
Table Dry Powder Inhaler Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table 3M Main Business
Table 3M Recent Development
Table Hovione Company Profile
Table Dry Powder Inhaler Product Introduction, Application and Specification of Hovione
Table Dry Powder Inhaler Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Hovione Main Business
Table Hovione Recent Development
Table Mannkind Company Profile
Table Dry Powder Inhaler Product Introduction, Application and Specification of Mannkind
Table Dry Powder Inhaler Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Mannkind Main Business
Table Mannkind Recent Development
Table Mylan Company Profile
Table Dry Powder Inhaler Product Introduction, Application and Specification of Mylan
Table Dry Powder Inhaler Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Mylan Main Business
Table Mylan Recent Development
Table Novartis Company Profile
Table Dry Powder Inhaler Product Introduction, Application and Specification of Novartis
Table Dry Powder Inhaler Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Novartis Main Business
Table Novartis Recent Development
Table Schering/Merck Company Profile
Table Dry Powder Inhaler Product Introduction, Application and Specification of Schering/Merck
Table Dry Powder Inhaler Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Schering/Merck Main Business
Table Schering/Merck Recent Development
Table Teva Company Profile
Table Dry Powder Inhaler Product Introduction, Application and Specification of Teva
Table Dry Powder Inhaler Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Teva Main Business
Table Teva Recent Development
Table Vectura Company Profile
Table Dry Powder Inhaler Product Introduction, Application and Specification of Vectura
Table Dry Powder Inhaler Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Vectura Main Business
Table Vectura Recent Development
Figure Global Dry Powder Inhaler Sales and Growth Rate (2017-2022)
Figure Global Dry Powder Inhaler Revenue and Growth Rate (2017-2022)
Table Global Dry Powder Inhaler Sales by Regions (2017-2022)
Figure Global Dry Powder Inhaler Sales Market Share by Regions in 2021
Table Global Dry Powder Inhaler Revenue by Regions (2017-2022)
Figure Global Dry Powder Inhaler Revenue Market Share by Regions in 2021
Figure North America Dry Powder Inhaler Sales and Growth Rate (2017-2022)
Figure Europe Dry Powder Inhaler Sales and Growth Rate (2017-2022)
Figure China Dry Powder Inhaler Sales and Growth Rate (2017-2022)
Figure Japan Dry Powder Inhaler Sales and Growth Rate (2017-2022)
Figure Southeast Asia Dry Powder Inhaler Sales and Growth Rate (2017-2022)
Figure Other Regions Dry Powder Inhaler Sales and Growth Rate (2017-2022)
Table Global Dry Powder Inhaler Sales by Big Type (2017-2022)
Table Global Dry Powder Inhaler Sales Market Share by Big Type (2017-2022)
Figure Global Dry Powder Inhaler Sales Market Share by Big Type in 2019
Table Global Dry Powder Inhaler Revenue by Big Type (2017-2022)
Table Global Dry Powder Inhaler Revenue Market Share by Big Type (2017-2022)
Table Global Dry Powder Inhaler Revenue Market Share by Big Type in 2019
Figure Global Single Dose Sales Growth Rate (2017-2022)
Figure Global Single Dose Price (2017-2022)
Figure Global Multi-dose Sales Growth Rate (2017-2022)
Table Global Dry Powder Inhaler Sales by Big Application (2017-2022)
Table Global Dry Powder Inhaler Sales Market Share by Big Application (2017-2022)
Figure Global Dry Powder Inhaler Sales Market Share by Big Application in 2019
Figure Global Asthma Sales Growth Rate (2017-2022)
Figure Global COPD Sales Growth Rate (2017-2022)
Figure Global Other Sales Growth Rate (2017-2022)
Figure Global Dry Powder Inhaler Sales and Growth Rate (2022-2027)
Figure Global Dry Powder Inhaler Revenue and Growth Rate (2022-2027)
Table Global Dry Powder Inhaler Sales Forecast by Regions (2022-2027)
Table Global Dry Powder Inhaler Market Share Forecast by Regions (2022-2027)
Figure North America Sales Dry Powder Inhaler Market Forecast (2022-2027)
Figure Europe Sales Dry Powder Inhaler Market Forecast (2022-2027)
Figure China Sales Dry Powder Inhaler Market Forecast (2022-2027)
Figure Japan Sales Dry Powder Inhaler Market Forecast (2022-2027)
Figure Southeast Asia Sales Dry Powder Inhaler Market Forecast (2022-2027)
Figure Other Regions Sales Dry Powder Inhaler Market Forecast (2022-2027)
Table Global Dry Powder Inhaler Sales Forecast by Type (2022-2027)
Table Global Dry Powder Inhaler Market Share Forecast by Type (2022-2027)
Table Global Dry Powder Inhaler Sales Forecast by Application (2022-2027)
Table Global Dry Powder Inhaler Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Dry Powder Inhaler
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Dry Powder Inhaler Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Dry Powder Inhaler Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Dry Powder Inhaler Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Dry Powder Inhaler Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Dry Powder Inhaler Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Dry Powder Inhaler Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Dry Powder Inhaler Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Dry Powder Inhaler Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
3M
Hovione
Mannkind
Mylan
Novartis
Schering/Merck
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)